Join us for 2 days of insightful discussion, vigorous debate and generous networking at the 31st annual Cancer Progress Conference May 5-6 in NYC. Guests include eminent Keynote Speaker Michael A. Curran, PhD (Associate Professor, Dept. of Immunology Scientific Director ORBIT Platform, The University of Texas MD Anderson Cancer Center, Department of Immunology, Division of Basic Sciences)
Cello Health and BresMed join forces to support value demonstration and optimise patient access for new biopharma therapies
Join us at the Pharmaceutical Management Science Association Virtual Meeting December 3-4, 2020 and visit our poster on Analogue Intelligence: Growing Both Players in a Duopoly Market, a case study from our growing practice in identifying and extracting learnings from analogues facing similar strategic challenges.
The acquisition of Cello Health provides the foundation for a new enterprise to enable healthcare and biopharmaceutical clients to maximize the value of their products.
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us